Balance Sheet Subaru Corporation

Equities

7270

JP3814800003

Auto & Truck Manufacturers

Market Closed - Japan Exchange Other stock markets 06:30:00 11/03/2026 GMT			5-day change	1st Jan Change
2,712.00 ^JPY	+0.50%		-1.26%	-20.12%

03-09	Blue-chip DAX Index Stays in the Red Amid Oil Price Surge, Downbeat German Industrial Data	MT
03-04	Stellantis, Toyota, Subaru not in Tesla carbon pool for 2026, EU filing shows	RE

1ce8f19b17c27b70db.cZJWdd_BNkby_EK8DXA5ZXSivEs79rOsh2wVQQqRPHI.HKA3AZSHYA-npTOMYRxSBwfI7iwOwODp8DhFdWLydz1GqzsyiZhyNLWmcg

Published financial data: SUBARU CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,830B	2,745B	3,774B	4,703B	4,686B
Total Revenues	2,830B	2,745B	3,774B	4,703B	4,686B
Cost of Goods Sold, Total	2,338B	2,241B	3,038B	3,711B	3,705B
Gross Profit	493B	504B	736B	992B	980B
Selling General & Admin Expenses, Total	252B	273B	309B	332B	352B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	104B	104B	114B	114B	142B
Depreciation & Amortization - (IS)	27.45B	30.44B	33.48B	35.68B	38.86B
Other Operating Expenses	4.48B	3.21B	8.83B	35.01B	33.5B
Other Operating Expenses, Total	389B	410B	465B	517B	567B
Operating Income	104B	93.99B	271B	476B	413B
Interest Expense, Total	-1.95B	-1.78B	-2.13B	-2.52B	-4.11B
Interest And Investment Income	4.82B	7.08B	26.84B	55.48B	70.58B
Net Interest Expenses	2.87B	5.3B	24.7B	52.96B	66.47B
Income (Loss) On Equity Invest.	-120M	-1.31B	141M	-899M	10M
Currency Exchange Gains (Loss)	3.49B	7.5B	-8.75B	17.11B	-34.94B
Other Non Operating Income (Expenses)	4.86B	3.3B	718M	-67M	-236M
EBT, Excl. Unusual Items	115B	109B	288B	545B	444B
Gain (Loss) On Sale Of Investments	10.18B	1.86B	-10.05B	5.29B	-2.18B
Gain (Loss) On Sale Of Assets	-4.66B	-5.08B	-980M	-7.01B	-8.05B
Asset Writedown	-6.75B	1.39B	5.19B	-10.62B	14.38B
Legal Settlements	-	-	-3.84B	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	114B	107B	278B	533B	449B
Income Tax Expense	36.63B	36.38B	79.28B	148B	110B
Earnings From Continuing Operations	77.32B	70.6B	199B	385B	338B
Net Income to Company	77.32B	70.6B	199B	385B	338B
Minority Interest	-810M	-589M	1.35B	514M	-90M
Net Income - (IS)	76.51B	70.01B	200B	385B	338B
Net Income to Common Incl Extra Items	76.51B	70.01B	200B	385B	338B
Net Income to Common Excl. Extra Items	76.51B	70.01B	200B	385B	338B
Per Share Items
Net EPS - Basic	99.77	91.28	261.33	509.2	458.03
Basic EPS - Continuing Operations	99.77	91.28	261.33	509.2	458.03
Basic Weighted Average Shares Outstanding	767M	767M	767M	756M	738M
Net EPS - Diluted	99.77	91.28	261.32	509.18	458
Diluted EPS - Continuing Operations	99.77	91.28	261.32	509.18	458
Diluted Weighted Average Shares Outstanding	767M	767M	767M	756M	738M
Normalized Basic EPS	92.82	87.9	236.49	451.01	376.15
Normalized Diluted EPS	92.82	87.9	236.48	450.99	376.13
Dividend Per Share	56	56	76	86	115
Payout Ratio	56.13	61.33	25.24	16.93	23.26
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	310B	318B	511B	694B	646B
EBITA	104B	93.99B	271B	476B	413B
EBIT	104B	93.99B	271B	476B	413B
Effective Tax Rate - (Ratio)	32.15	34.01	28.48	27.79	24.6
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	71.18B	67.41B	181B	341B	278B
Non-Cash Pension Expense	6.35B	5.34B	9.27B	11.98B	13.54B
Supplemental Operating Expense Items
Advertising Expense	69.72B	76.67B	84.48B	101B	108B
Selling and Marketing Expenses	84.15B	93.29B	106B	125B	133B
Research And Development Expense From Footnotes	104B	104B	114B	114B	160B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	907B	883B	980B	1,048B	941B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	907B	883B	980B	1,048B	941B
Accounts Receivable, Total	342B	337B	358B	376B	412B
Other Receivables	19.82B	18.33B	11.05B	12.24B	17.63B
Notes Receivable	-	-	-	-	-
Total Receivables	362B	356B	369B	388B	429B
Inventory	419B	483B	593B	589B	667B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	295B	320B	489B	994B	1,153B
Total Current Assets	1,983B	2,042B	2,430B	3,019B	3,191B
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	840B	842B	862B	969B	1,062B
Long-term Investments	264B	319B	336B	462B	416B
Other Intangibles, Total	217B	251B	244B	291B	317B
Deferred Tax Assets Long-Term	109B	90.55B	73.06B	72.63B	103B
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	3,412B	3,544B	3,944B	4,814B	5,088B
Liabilities
Accounts Payable, Total	268B	274B	377B	385B	426B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	1.34B	493M	194M	-	-
Current Portion of Long-Term Debt	24.99B	51.15B	55.4B	69B	47B
Current Portion of Leases	30.17B	33.36B	31.85B	35.8B	32.73B
Current Income Taxes Payable	2.91B	4.68B	27.2B	93.08B	51.83B
Other Current Liabilities	548B	489B	522B	649B	705B
Total Current Liabilities	875B	852B	1,013B	1,231B	1,262B
Long-Term Debt	308B	282B	257B	330B	352B
Long-Term Leases	71.47B	73.76B	82.67B	88.05B	98.12B
Pension & Other Post Retirement Benefits	55.82B	58.2B	55.56B	62.5B	66.66B
Deferred Tax Liability Non Current	7.85B	5.06B	286M	178M	140M
Other Non Current Liabilities	308B	371B	425B	537B	593B
Total Liabilities	1,625B	1,643B	1,834B	2,249B	2,373B
Common Stock, Total	154B	154B	154B	154B	154B
Additional Paid In Capital	160B	160B	160B	160B	160B
Retained Earnings	1,435B	1,466B	1,624B	1,907B	2,106B
Treasury Stock	-6.52B	-6.32B	-6.14B	-4.62B	-4.65B
Comprehensive Income and Other	35B	117B	169B	347B	298B
Total Common Equity	1,778B	1,891B	2,101B	2,563B	2,715B
Minority Interest	8.65B	10.23B	8.97B	2.19B	1.19B
Total Equity	1,786B	1,901B	2,110B	2,565B	2,716B
Total Liabilities And Equity	3,412B	3,544B	3,944B	4,814B	5,088B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	767M	767M	767M	752M	731M
ECS Total Common Shares Outstanding	767M	767M	767M	752M	731M
Book Value / Share	2.32K	2.47K	2.74K	3.41K	3.71K
Tangible Book Value	1,561B	1,640B	1,857B	2,272B	2,398B
Tangible Book Value Per Share	2.04K	2.14K	2.42K	3.02K	3.28K
Total Debt	436B	441B	427B	523B	530B
Net Debt	-472B	-442B	-552B	-525B	-411B
Debt Equivalent of Unfunded Proj. Benefit Obligation	54.03B	54.79B	50.24B	50.32B	51.5B
Minority Interest, Total (Incl. Fin. Div)	8.65B	10.23B	8.97B	2.19B	1.19B
Equity Method Investments, Total	10.18B	10.83B	9.06B	8.16B	5.41B
Account Code - Inventory Valuation	-	-	-	-	-
Inventories - Raw Materials, Total	99.54B	128B	135B	130B	139B
Inventories - Work In Process, Total	82.2B	101B	110B	96.41B	115B
Inventories - Finished Goods, Total	237B	254B	348B	362B	414B
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Full Time Employees	36.07K	36.91K	37.52K	37.69K	37.87K
Assets on Operating Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-
Order Backlog	215B	301B	313B	567B	644B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	114B	107B	278B	533B	449B
Depreciation & Amortization - CF	206B	224B	240B	218B	233B
Depreciation & Amortization, Total	206B	224B	240B	218B	233B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	120M	1.31B	-141M	899M	-10M
Other Operating Activities, Total	-46.14B	-37.33B	-23.04B	-127B	-155B
Change In Accounts Receivable	24.46B	7.69B	-14.99B	-7.32B	-31.04B
Change In Inventories	39.56B	-42.35B	-92.05B	51.81B	-92.48B
Change In Accounts Payable	-62.05B	-4.8B	97.79B	-8.23B	19.79B
Change in Other Net Operating Assets	13.15B	-59.9B	18B	107B	70.05B
Cash from Operations	289B	196B	504B	768B	492B
Capital Expenditure	-125B	-101B	-135B	-188B	-171B
Sale of Property, Plant, and Equipment	568M	1.86B	5.98B	2.84B	2.18B
Sale (Purchase) of Intangible assets	-67.8B	-84.99B	-59.87B	-112B	-94.43B
Investment in Marketable and Equity Securities, Total	3.04B	-5.44B	-110B	-366B	-148B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	9.39B
Other Investing Activities, Total	-83.26B	10.1B	-37.59B	-40.57B	-2.58B
Cash from Investing	-272B	-180B	-337B	-704B	-404B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	106B	26B	30B	142B	69B
Total Debt Issued	106B	26B	30B	142B	69B
Short Term Debt Repaid, Total	-540M	-900M	-300M	-201M	-
Long-Term Debt Repaid, Total	-7.42B	-24.99B	-51.15B	-55.4B	-69B
Total Debt Repaid	-7.96B	-25.89B	-51.45B	-55.6B	-69B
Repurchase of Common Stock	-	-	-	-40.01B	-60B
Common Dividends Paid	-42.95B	-42.93B	-50.6B	-65.2B	-78.64B
Common & Preferred Stock Dividends Paid	-42.95B	-42.93B	-50.6B	-65.2B	-78.64B
Other Financing Activities, Total	-40.63B	-55.68B	-50.26B	-48.16B	-48.68B
Cash from Financing	13.97B	-98.5B	-122B	-66.47B	-187B
Foreign Exchange Rate Adjustments	17.19B	58.32B	51.82B	70.97B	-7.28B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	48.36B	-24.25B	96.46B	68.47B	-107B
Supplemental Items
Cash Interest Paid	2.01B	1.96B	2.34B	2.65B	4.6B
Cash Income Tax Paid (Refund)	37.77B	25.91B	34.04B	110B	173B
Levered Free Cash Flow	-7.81B	-39.6B	80.85B	-107B	843M
Unlevered Free Cash Flow	-6.59B	-38.49B	82.18B	-106B	3.41B
Change In Net Working Capital	85.44B	135B	132B	321B	222B
Net Debt Issued / Repaid	97.54B	109M	-21.45B	86.9B	0

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.94	1.69	4.53	6.79	5.21
Return on Total Capital	3.05	2.57	6.95	10.57	8.15
Return On Equity %	4.41	3.83	9.93	16.45	12.81
Return on Common Equity	4.38	3.82	10.04	16.51	12.81
Margin Analysis
Gross Profit Margin %	17.4	18.36	19.51	21.1	20.92
SG&A Margin	8.92	9.94	8.17	7.07	7.52
EBITDA Margin %	10.97	11.59	13.54	14.75	13.78
EBITA Margin %	3.68	3.42	7.19	10.12	8.81
EBIT Margin %	3.68	3.42	7.19	10.12	8.81
Income From Continuing Operations Margin %	2.73	2.57	5.27	8.18	7.22
Net Income Margin %	2.7	2.55	5.31	8.19	7.21
Net Avail. For Common Margin %	2.7	2.55	5.31	8.19	7.21
Normalized Net Income Margin	2.52	2.46	4.81	7.25	5.92
Levered Free Cash Flow Margin	-0.28	-1.44	2.14	-2.28	0.02
Unlevered Free Cash Flow Margin	-0.23	-1.4	2.18	-2.24	0.07
Asset Turnover
Asset Turnover	0.84	0.79	1.01	1.07	0.95
Fixed Assets Turnover	3.41	3.26	4.43	5.14	4.61
Receivables Turnover (Average Receivables)	8.01	8.08	10.86	12.82	11.89
Inventory Turnover (Average Inventory)	5.32	4.97	5.65	6.28	5.9
Short Term Liquidity
Current Ratio	2.27	2.4	2.4	2.45	2.53
Quick Ratio	1.45	1.45	1.33	1.17	1.09
Operating Cash Flow to Current Liabilities	0.33	0.23	0.5	0.62	0.39
Days Sales Outstanding (Average Receivables)	45.57	45.17	33.6	28.55	30.69
Days Outstanding Inventory (Average Inventory)	68.62	73.48	64.64	58.27	61.86
Average Days Payable Outstanding	48	42.87	37.73	37.62	39.08
Cash Conversion Cycle (Average Days)	66.2	75.78	60.51	49.21	53.47
Long Term Solvency
Total Debt/Equity	24.38	23.21	20.24	20.4	19.53
Total Debt / Total Capital	19.6	18.84	16.84	16.94	16.34
LT Debt/Equity	21.22	18.74	16.1	16.32	16.59
Long-Term Debt / Total Capital	17.06	15.21	13.39	13.55	13.88
Total Liabilities / Total Assets	47.64	46.36	46.5	46.71	46.63
EBIT / Interest Expense	53.49	52.95	127.1	188.44	100.5
EBITDA / Interest Expense	159.51	179.18	239.48	274.69	157.08
(EBITDA - Capex) / Interest Expense	95.42	122.14	176.22	200.17	115.51
Total Debt / EBITDA	1.4	1.39	0.84	0.75	0.82
Net Debt / EBITDA	-1.52	-1.39	-1.08	-0.76	-0.64
Total Debt / (EBITDA - Capex)	2.35	2.03	1.14	1.04	1.12
Net Debt / (EBITDA - Capex)	-2.54	-2.04	-1.47	-1.04	-0.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-15.37	-3.03	37.53	24.6	-0.37
Gross Profit, 1 Yr. Growth %	-19.97	2.3	46.15	34.75	-1.22
EBITDA, 1 Yr. Growth %	-23.57	2.46	60.68	35.72	-6.92
EBITA, 1 Yr. Growth %	-51.22	-9.7	188.57	75.42	-13.19
EBIT, 1 Yr. Growth %	-51.22	-9.7	188.57	75.42	-13.19
Earnings From Cont. Operations, 1 Yr. Growth %	-49.33	-8.7	182	93.17	-12.07
Net Income, 1 Yr. Growth %	-49.86	-8.5	186.3	92.13	-12.21
Normalized Net Income, 1 Yr. Growth %	-46.63	-5.3	169.07	88.05	-18.6
Diluted EPS Before Extra, 1 Yr. Growth %	-49.86	-8.51	186.27	94.85	-10.05
Accounts Receivable, 1 Yr. Growth %	-6.29	-1.32	5.97	5.24	9.43
Inventory, 1 Yr. Growth %	-8.89	15.29	22.75	-0.76	13.4
Net Property, Plant and Equip., 1 Yr. Growth %	2.33	0.23	2.41	12.44	9.57
Total Assets, 1 Yr. Growth %	3.58	3.87	11.3	22.06	5.69
Tangible Book Value, 1 Yr. Growth %	3.86	5.05	13.24	22.33	5.56
Common Equity, 1 Yr. Growth %	3.79	6.36	11.12	22	5.9
Cash From Operations, 1 Yr. Growth %	37.71	-32.39	157.48	52.39	-35.89
Capital Expenditures, 1 Yr. Growth %	-5.29	-18.82	33.33	39.37	-9.19
Levered Free Cash Flow, 1 Yr. Growth %	-95.81	407.21	-304.16	-232.51	-100.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-96.44	483.98	-313.51	-228.44	-103.23
Dividend Per Share, 1 Yr. Growth %	-44	0	35.71	13.16	33.72
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.37	-9.41	15.48	30.9	11.42
Gross Profit, 2 Yr. CAGR %	-9.3	-9.52	22.27	40.34	15.37
EBITDA, 2 Yr. CAGR %	2.23	-11.51	28.31	47.67	12.4
EBITA, 2 Yr. CAGR %	-26.8	-33.63	61.42	124.99	23.4
EBIT, 2 Yr. CAGR %	-26.8	-33.63	61.42	124.99	23.4
Earnings From Cont. Operations, 2 Yr. CAGR %	-27.56	-31.98	60.46	133.4	30.33
Net Income, 2 Yr. CAGR %	-28.05	-32.27	61.85	134.53	29.87
Normalized Net Income, 2 Yr. CAGR %	-25.28	-28.9	59.63	124.94	23.72
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.06	-32.27	61.84	136.18	32.39
Accounts Receivable, 2 Yr. CAGR %	44.73	-3.84	2.26	5.6	7.31
Inventory, 2 Yr. CAGR %	3.56	2.49	18.96	10.37	6.09
Net Property, Plant and Equip., 2 Yr. CAGR %	8.19	1.28	1.31	7.31	11
Total Assets, 2 Yr. CAGR %	6.95	3.72	7.52	16.55	13.58
Tangible Book Value, 2 Yr. CAGR %	-0.33	4.45	9.07	17.7	13.63
Common Equity, 2 Yr. CAGR %	5.23	5.06	8.71	16.43	13.67
Cash From Operations, 2 Yr. CAGR %	28.96	-3.51	31.94	98.08	-1.16
Capital Expenditures, 2 Yr. CAGR %	-6.99	-12.32	4.04	36.32	12.5
Levered Free Cash Flow, 2 Yr. CAGR %	-72.92	-53.88	221.8	64.48	-89.79
Unlevered Free Cash Flow, 2 Yr. CAGR %	-75.18	-54.39	253.11	65.6	-79.62
Dividend Per Share, 2 Yr. CAGR %	-37.64	-25.17	16.5	23.92	23.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.98	-4.6	4.12	18.45	19.52
Gross Profit, 3 Yr. CAGR %	-20.01	-5.59	6.16	26.3	24.84
EBITDA, 3 Yr. CAGR %	-13.56	2.31	7.96	30.73	26.62
EBITA, 3 Yr. CAGR %	-34.97	-21.49	8.32	65.96	63.79
EBIT, 3 Yr. CAGR %	-34.97	-21.49	8.32	65.96	63.79
Earnings From Cont. Operations, 3 Yr. CAGR %	-29.61	-21.75	9.27	70.7	68.57
Net Income, 3 Yr. CAGR %	-29.71	-22.05	9.52	71.37	69.03
Normalized Net Income, 3 Yr. CAGR %	-32.81	-19.14	10.79	68.59	60.29
Diluted EPS Before Extra, 3 Yr. CAGR %	-29.72	-22.06	9.51	72.17	71.19
Accounts Receivable, 3 Yr. CAGR %	25.73	27.39	-0.67	3.24	6.86
Inventory, 3 Yr. CAGR %	12.14	7.33	8.84	11.98	11.37
Net Property, Plant and Equip., 3 Yr. CAGR %	6.09	5.46	1.65	4.9	8.06
Total Assets, 3 Yr. CAGR %	5.76	5.91	6.19	12.16	12.82
Tangible Book Value, 3 Yr. CAGR %	0.79	1.43	7.3	13.32	13.5
Common Equity, 3 Yr. CAGR %	4.61	5.61	7.04	12.97	12.81
Cash From Operations, 3 Yr. CAGR %	-7.56	3.99	33.84	38.43	36
Capital Expenditures, 3 Yr. CAGR %	-5.94	-11.11	0.83	14.69	19.06
Levered Free Cash Flow, 3 Yr. CAGR %	-67.45	-28.09	-24.28	139.41	-72.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	-69.27	-28.87	-23.71	152.06	-55.41
Dividend Per Share, 3 Yr. CAGR %	-27.01	-27.01	-8.74	15.37	27.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.62	-3.77	2.08	8.27	6.98
Gross Profit, 5 Yr. CAGR %	-13.97	-11.72	-5.21	10.63	9.76
EBITDA, 5 Yr. CAGR %	-13.42	-8.49	1.24	18.49	9.71
EBITA, 5 Yr. CAGR %	-28.71	-25.51	-6.44	19.62	14.12
EBIT, 5 Yr. CAGR %	-28.71	-25.51	-6.44	19.62	14.12
Earnings From Cont. Operations, 5 Yr. CAGR %	-29.26	-24.28	-2.13	21.15	17.25
Net Income, 5 Yr. CAGR %	-29.41	-24.34	-1.88	21.11	17.25
Normalized Net Income, 5 Yr. CAGR %	-27.8	-23.05	-5.02	21.75	15.79
Diluted EPS Before Extra, 5 Yr. CAGR %	-29.17	-24.24	-1.88	21.44	18.14
Accounts Receivable, 5 Yr. CAGR %	16.16	13.79	15.76	18.18	2.45
Inventory, 5 Yr. CAGR %	8.53	9.9	14.82	8.54	7.73
Net Property, Plant and Equip., 5 Yr. CAGR %	7.96	5.07	4.16	6.2	5.29
Total Assets, 5 Yr. CAGR %	5.65	5.11	6.46	10.05	9.09
Tangible Book Value, 5 Yr. CAGR %	3.37	2.72	4.02	7.65	9.79
Common Equity, 5 Yr. CAGR %	5.76	5.33	6.23	9.81	9.65
Cash From Operations, 5 Yr. CAGR %	-13.98	-10.75	6.58	34.56	18.55
Capital Expenditures, 5 Yr. CAGR %	-0.32	-9.17	-2.07	5.47	5.35
Levered Free Cash Flow, 5 Yr. CAGR %	-54.87	-21.22	-18.61	0.12	-66.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	-56.4	-21.81	-18.4	-0.26	-55.01
Dividend Per Share, 5 Yr. CAGR %	-17.21	-17.21	-12	-9.8	2.83